Loading...
Keywords
Last Name
Institution

Stephani L. Stancil, PhD, APRN

TitleClinician Scientist, Adolescent Medicine
InstitutionChildren's Mercy Kansas City
DepartmentPediatrics
Address3101 Broadway Boulevard
Kansas City MO 64111
ORCID ORCID Icon0000-0001-7308-3132 Additional info
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUniversity of Missouri-Kansas City
    DepartmentPediatrics


    Collapse Biography 
    Collapse education and training
    Children's Mercy Hospital, Kansas City, MOT32 Fellowship08/2020Pediatric Clinical Pharmacology
    University of Missouri Kansas City, Kansas City, MOPh.D07/2018Pharmacology and Pharmaceutical Science
    University of Kansas, Lawrence, KSMS08/2009Family Nurse Practitioner
    Collapse awards and honors
    2019National Magnet Nurse of the Year - Exemplary Professional Practice, American Nurses Credentialing Center (ANCC)
    2022Research Achievement - Early Career Faculty, Children's Mercy Department of Pediatrics

    Collapse Overview 

    Collapse Research 
    Collapse research overview
    Stephani Stancil, PhD, APRN is an adolescent medicine clinician scientist in the Divisions of Adolescent Medicine and Clinical Pharmacology, Toxicology and Therapeutic Innovation at Children's Mercy and an assistant professor in the Department of Pediatrics at the University of Missouri-Kansas City School of Medicine. For over a decade, her clinical practice has focused on complex teens in specialized and vulnerable populations. Her interdisciplinary, translational research focuses on developing precision therapeutics for adolescent mental health conditions by understanding variability in exposure and response. Her other research interests include improving reproductive health care in teens and reducing risks of vulnerable youth. She recently served as an editor-in-training for the ASCPT journal, Clinical and Translational Science and now serves on their editorial board.
    Collapse research activities and funding
    K23MH130728     
    NIMH
    Development of a Pharmacodynamic Biomarker of Opioid Antagonism in Adolescents with Eating Disorders
    Role Description: Eating disorders are common in adolescents, increase the risk of substance use, have the highest mortality rate of any psychiatric illness and are not responsive to current pharmacotherapy. The overall goal of this K23 proposal is to evaluate neuroimaging as a pharmacodynamic biomarker of opioid antagonism in adolescents with eating disorders through practical application of training in neuroimaging, pediatric randomized clinical trials and exposure-response modeling. At the completion of this proposal, Dr. Stephani Stancil will be well- positioned for an independent career as an interdisciplinary translational scientist focused on pharmacodynamic biomarker development to support early-stage drug development in pediatric neuropsychopharmacology.
    Role: Primary Investigator

    T32HD069038     (GOLDMAN, JENNIFER LYNN;WAGNER, JONATHAN)May 1, 2011 - Apr 30, 2026
    NIH
    Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
    Role: Fellow

         (Miller, Melissa K)Jun 15, 2014 - Jun 14, 2015
    Kansas City Area Life Sciences Institute
    Novel computerized decision support system to increase access to sexual health services for adolescents in the emergency department
    Role: Co-Investigator

    Young Investigator Award     (Stancil, Stephani L)Jul 1, 2014 - Jun 30, 2016
    Children's Mercy
    Exploring the effects of nicotine and ethinyl estradiol on the metabolism of metronidazole
    Role: Primary Investigator

    Katharine B. Richardson Award     (Stancil, Stephani L)Jan 1, 2016 - Dec 31, 2017
    Children's Mercy
    Validation of a novel CYP2A6 in vivo phenotyping probe in healthy adults
    Role: Primary Investigator

    K23HD083405     (MILLER, MELISSA KRISTINE)May 11, 2016 - Apr 30, 2020
    NIH
    Enhanced Intervention to Improve Adolescent Outcomes: A Clinical Trial
    Role: Co-Investigator

    U54HD090258     (LEEDER, JAMES STEVEN)Sep 23, 2016 - Jun 30, 2021
    NIH
    Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids
    Role: Pilot project PI

    Fellow's Award     (Stancil, Stephani L)Jul 1, 2019 - Jun 30, 2021
    Children's Mercy
    Eating Disorder Individualized Therapeutics-Naltrexone
    Role: Primary Investigator

    R21HD098086     (MILLER, MELISSA KRISTINE)May 22, 2020 - Apr 30, 2022
    NIH
    Multi-level Emergency Department Intervention to Reduce Pregnancy Risk Among Adolescents
    Role: Co-Investigator

         (Masonbrink, Abbey)Jun 1, 2020 - May 31, 2022
    Merck
    Intervention to Facilitate Contraception Provision by Pediatric Hospitalists: A Feasibility Study
    Role: Co-Investigator

         (Stancil, Stephani L)Aug 10, 2020 - Dec 31, 2020
    CARES Act
    Smarter together: A MidWest collaboration to develop best practices for community youth shelters facing COVID-19
    Role: Primary Investigator

    UL1TR002366     Jul 1, 2021 - Jun 30, 2022
    NCATS
    Eating Disorder Individualized Therapeutics - Naltrexone Neuroimaging
    Role: Primary Investigator (pilot grant recipient)

         (Stephani Stancil)Jan 1, 2022 - Dec 31, 2023
    Paul Patton Trust
    Antidepressant Exposure in the Adolescent Brain
    Role: Co-Primary Investigator

    KL2TR002367     (Stephani Stancil)Jul 29, 2022 - Jun 30, 2023
    NCATS
    Development of a Pharmacodynamic Biomarker of Opioid Antagonism
    Role: Primary Investigator

    Collapse Bibliography 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Stancil SL, Sandritter T, Strawn JR. Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B*15:02. J Child Adolesc Psychopharmacol. 2024 Feb; 34(1):61-66. PMID: 38377523.
      View in: PubMed
    2. Stancil SL, Pearce RE, Staggs VS, Leeder JS. Ontogeny of Scaling Factors for Pediatric Physiologically Based Pharmacokinetic Modeling and Simulation: Cytosolic Protein Per Gram of Liver. Drug Metab Dispos. 2023 Dec; 51(12):1578-1582. PMID: 37735064.
      View in: PubMed
    3. Stancil SL, Yeh HW, Brucks MG, Bruce AS, Voss M, Abdel-Rahman S, Brooks WM, Martin LE. Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study. Front Psychiatry. 2023; 14:1161032. PMID: 37492067.
      View in: PubMed
    4. Masonbrink AR, Noel-MacDonnell J, Staggs VS, Stancil S, Goggin K, Miller MK. Feasibility of a Contraception Intervention for Hospitalized Adolescents and Young Adults. Hosp Pediatr. 2023 04 01; 13(4):337-344. PMID: 36897226.
      View in: PubMed
    5. Stancil SL, Voss M, Nolte W, Tumberger J, Adelman W, Abdel-Rahman S. Effects of genotype and food on naltrexone exposure in adolescents. Clin Transl Sci. 2022 Nov; 15(11):2732-2743. PMID: 36200172.
      View in: PubMed
    6. Stancil SL, Tumberger J, Strawn JR. Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry. Clin Transl Sci. 2022 04; 15(4):816-823. PMID: 34913258.
      View in: PubMed
    7. Stancil SL, Nolte W, Pearce RE, Staggs VS, Leeder JS. The Impact of Age and Genetics on Naltrexone Biotransformation. Drug Metab Dispos. 2022 02; 50(2):168-173. PMID: 34728519.
      View in: PubMed
    8. Stancil SL, Abdel-Rahman S, Wagner J. Developmental Considerations for the Use of Naltrexone in Children and Adolescents. J Pediatr Pharmacol Ther. 2021; 26(7):675-695. PMID: 34588931.
      View in: PubMed
    9. Stancil SL, Miller MK, Duello A, Finocchario-Kessler S, Goggin K, Winograd RP, Hurley EA. Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse. Harm Reduct J. 2021 08 04; 18(1):83. PMID: 34348734.
      View in: PubMed
    10. Stancil SL, Mirzayev F, Abdel-Rahman SM. Profiling Pretomanid as a Therapeutic Option for TB Infection: Evidence to Date. Drug Des Devel Ther. 2021; 15:2815-2830. PMID: 34234413.
      View in: PubMed
    11. Miller MK, Catley D, Adams A, Staggs VS, Dowd MD, Stancil SL, Miller E, Satterwhite CL, Bauermeister J, Goggin K. Brief Motivational Intervention to Improve Adolescent Sexual Health Service Uptake: A Pilot Randomized Controlled Trial in the Emergency Department. J Pediatr. 2021 Oct; 237:250-257.e2. PMID: 34144031.
      View in: PubMed
    12. Stancil SL, Berrios C, Abdel-Rahman S. Adolescent perceptions of pharmacogenetic testing. Pharmacogenomics. 2021 04; 22(6):335-343. PMID: 33849282.
      View in: PubMed
    13. Roberts TA, Wagner JA, Sandritter T, Black BT, Gaedigk A, Stancil SL. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital. Clin Transl Sci. 2021 01; 14(1):412-421. PMID: 33048453.
      View in: PubMed
    14. Hurley EA, Duello A, Finocchario-Kessler S, Goggin K, Stancil S, Winograd RP, Miller MK. Expanding Contraception Access for Women With Opioid-Use Disorder: A Qualitative Study of Opportunities and Challenges. Am J Health Promot. 2020 11; 34(8):909-918. PMID: 32468826.
      View in: PubMed
    15. Stancil SL, Adelman W, Dietz A, Abdel-Rahman S. Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program. J Child Adolesc Psychopharmacol. 2019 11; 29(9):721-724. PMID: 31313939.
      View in: PubMed
    16. Stancil SL, Pearce RE, Tyndale RF, Kearns GL, Vyhlidal CA, Leeder JS, Abdel-Rahman S. Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults. Br J Clin Pharmacol. 2019 05; 85(5):960-969. PMID: 30706508.
      View in: PubMed
    17. Masonbrink AR, Stancil S, Reid KJ, Goggin K, Hunt JA, Mermelstein SJ, Shafii T, Lehmann AG, Harhara H, Miller MK. Adolescent Reproductive Health Care: Views and Practices of Pediatric Hospitalists. Hosp Pediatr. 2019 02; 9(2):100-106. PMID: 30622112.
      View in: PubMed
    18. Miller MK, Mollen C, Behr K, Dowd MD, Miller E, Satterwhite CL, Stancil S, Allen N, Michael J, Inboriboon PC, Park A, Goggin K. Development of a Novel Computerized Clinical Decision Support System to Improve Adolescent Sexual Health Care Provision. Acad Emerg Med. 2019 04; 26(4):420-433. PMID: 30240032.
      View in: PubMed
    19. Stancil SL, van Haandel L, Abdel-Rahman S, Pearce RE. Development of a UPLC-MS/MS method for quantitation of metronidazole and 2-hydroxy metronidazole in human plasma and its application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15; 1092:272-278. PMID: 29933220.
      View in: PubMed
    20. Stancil SL, Miller M, Briggs H, Lynch D, Goggin K, Kearns G. Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications. Pediatrics. 2016 Jan; 137(1). PMID: 26676050.
      View in: PubMed
    Stancil's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description